(Q64990890)

2 July 2019

title

Intron retention is a source of neoepitopes in cancer. (English)

1 reference

2 July 2019

author

Claire A Margolis

2

1 reference

2 July 2019

Tim Fugmann

7

1 reference

2 July 2019

Kwok Kin Wong

8

1 reference

2 July 2019

author name string

Alicia C Smart

1

1 reference

2 July 2019

Harold Pimentel

3

1 reference

2 July 2019

Meng Xiao He

4

1 reference

2 July 2019

Diana Miao

5

1 reference

2 July 2019

Dennis Adeegbe

6

1 reference

2 July 2019

Eliezer M Van Allen

9

1 reference

2 July 2019

publication date

16 August 2018

1 reference

2 July 2019

published in

Nature Biotechnology

1 reference

2 July 2019

volume

36

1 reference

2 July 2019

issue

11

1 reference

2 July 2019

page(s)

1056-1058

1 reference

2 July 2019

https://scigraph.springernature.com/pub.10.1038/nbt.4239

exact match

0 references

cites work

An immunogenic personal neoantigen vaccine for patients with melanoma

1 reference

7 January 2021

Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.

1 reference

7 January 2021

Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells

1 reference

7 January 2021

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

1 reference

7 January 2021

A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response

1 reference

7 January 2021

Widespread intron retention diversifies most cancer transcriptomes

1 reference

7 January 2021

Intron retention is a widespread mechanism of tumor-suppressor inactivation.

1 reference

7 January 2021

Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation

1 reference

7 January 2021

Proteases in MHC class I presentation and cross-presentation

1 reference

7 January 2021

MHC class I-associated peptides derive from selective regions of the human genome

1 reference

7 January 2021

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

1 reference

7 January 2021

Genetic basis for clinical response to CTLA-4 blockade in melanoma

1 reference

7 January 2021

Detecting and correcting systematic variation in large-scale RNA sequencing data

1 reference

7 January 2021

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

1 reference

7 January 2021

Molecular and genetic properties of tumors associated with local immune cytolytic activity

1 reference

7 January 2021

IRFinder: assessing the impact of intron retention on mammalian gene expression.

1 reference

7 January 2021

An extensive program of periodic alternative splicing linked to cell cycle progression

1 reference

7 January 2021

CDK4/6 Inhibition Augments Anti-Tumor Immunity by Enhancing T Cell Activation.

1 reference

7 January 2021

The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade.

1 reference

7 January 2021

CDK4/6 inhibition triggers anti-tumour immunity.

1 reference

7 January 2021

Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage

1 reference

7 January 2021

High frequency of T cells specific for cryptic epitopes in melanoma patients

1 reference

7 January 2021

Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade

1 reference

7 January 2021

GENCODE: the reference human genome annotation for The ENCODE Project

1 reference

7 January 2021

Near-optimal probabilistic RNA-seq quantification

1 reference

7 January 2021

A dynamic intron retention program enriched in RNA processing genes regulates gene expression during terminal erythropoiesis

1 reference

7 January 2021

The UCSC Table Browser data retrieval tool

1 reference

7 January 2021

Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes

1 reference

7 January 2021

NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets

1 reference

7 January 2021

UniProt: the universal protein knowledgebase

1 reference

7 January 2021

Integrative genomics viewer

1 reference

7 January 2021

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

1 reference

7 January 2021

Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs

1 reference

7 January 2021

High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients' sera.

1 reference

7 January 2021

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

1 reference

7 January 2021

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

1 reference

7 January 2021

Identifiers

DOI

10.1038/NBT.4239

1 reference

2 July 2019

PMC publication ID

6226333

1 reference

2 July 2019

PubMed publication ID

30114007

1 reference

2 July 2019